Advertisement

Topics

Clinical Trials About "Buyable Senseonics" RSS

05:00 EST 19th December 2018 | BioPortfolio

We list hundreds of Clinical Trials about "Buyable Senseonics" on BioPortfolio. We draw our references from global clinical trials data listed on ClinicalTrials.gov and refresh our database daily.

More Information about "Buyable Senseonics" on BioPortfolio

We have published hundreds of Buyable Senseonics news stories on BioPortfolio along with dozens of Buyable Senseonics Clinical Trials and PubMed Articles about Buyable Senseonics for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Buyable Senseonics Companies in our database. You can also find out about relevant Buyable Senseonics Drugs and Medications on this site too.

Showing "Buyable Senseonics" Clinical Trials, all 4

Relevant

A Feasibility Trial to Evaluate the Senseonics Continuous Glucose Monitoring System in Canada

The purpose of this clinical investigation is to evaluate the effectiveness of modified Sensor designs on the longevity (up to 180 days) of the Senseonics Continuous Glucose Monitoring (CGM) System. The investigation will also evaluate safety of the Senseonics CGM System usage, while in the clinic and during home use.


Evaluation of the Accuracy of an Implanted Glucose Sensor

The purpose of this clinical investigation is to evaluate the accuracy of the Senseonics Continuous Glucose Monitoring System (Senseonics CGM System) measurements when compared with reference standard measurements The investigation will also evaluate safety of the Senseonics CGM System usage.

Home Use Sensor Study

The purpose of this clinical investigation is to evaluate the accuracy of the Eversense Continuous Glucose Monitoring System (Eversense System) measurements when compared with a Self-monitoring blood glucose (SMBG) meter. The investigation will assess device performance in two insertion locations (abdomen and upper arm), evaluate safety of the Eversense System usage, and assess the usability of the Eversense system in the hands of user at home setting. Changes in HbA1c from bas...


Probably Relevant

Eversense and Dexcom G5: Efficacy and Accuracy in Type 1 Diabetic Patients

Continuous Glucose Monitoring (CGM) systems improve glycaemic control in type 1 diabetic patients but they have different characteristics that could influence patients' quality of life and glycaemic control. In this randomized cross over study investigators will compare 2 different CGM systems: Eversense implantable sensor (Senseonics, Germantown, MD, USA) and the standard transcutaneous sensor Dexcom G5 (Dexcom, San Diego, CA, USA). Investigators will evaluate sensors' ...


More From BioPortfolio on "Buyable Senseonics"

Advertisement
Quick Search
Advertisement
Advertisement